Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Designing a HER2/neu promoter to drive alpha1,3galactosyltransferase expression for targeted anti-alphaGal antibody-mediated tumor cell killing.
Lanteri M, Ollier L, Giordanengo V, Lefebvre JC
Breast Cancer Res 2005, 7:R487-94
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research    
Development of a novel small antibody that retains specificity for tumor targeting
Zhen ZP, Zhang J, Zhang SY
Journal of Experimental & Clinical Cancer Research 2009, 28:59 (30 April 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.